In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Diagnostic yield of invasive coronary angiography in a uk district general hospital.

Session Poster session 1

Speaker Floyd Pierres

Event : ESC Congress 2017

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Coronary Artery Disease (Chronic)
  • Session type : Poster Session

Authors : A Rauf (London,GB), S J Denny (London,GB), F Pierres (London,GB), A Jackson (London,GB), N Papamichail (London,GB), A Pavlidis (London,GB), K Alfakih (London,GB)

Authors:
A. Rauf1 , S.J. Denny1 , F. Pierres1 , A. Jackson1 , N. Papamichail1 , A. Pavlidis1 , K. Alfakih1 , 1Lewisham Healthcare NHS Trust - London - United Kingdom ,

Citation:
European Heart Journal ( 2017 ) 38 ( Supplement ), 200-201

Introduction: Invasive coronary angiography (ICA) remains the gold standard for the diagnosis of patients with stable coronary artery disease (CAD) and acute coronary syndromes (ACS). A large American registry in 2010 demonstrated a low diagnostic yield.1 Furthermore, In 2010 UK NICE guidelines recommended that patients with chest pain and high pre-test probability (PTP) of CAD, should go directly to ICA. Cardiac CT and functional imaging tests were recommended for patients with low and intermediate PTP respectively.

Purpose: Assess the diagnostic yield of ICA in stable chest pain and ACS.

Method: We examined our catheter lab database for all patients who had ICA, over a 12 month period, for new onset chest pain and ACS. We classified patients into 1) severe CAD 2) moderate CAD and 3) normal coronaries and mild CAD.

Results: In total, 707 underwent ICA (mean age 64 and 56% male). Of these, 457 were for stable chest pain and 250 were for ACS. The yield of severe CAD for the whole cohort was 41%. The yield was much higher in patients with ACS with 55% found to have severe CAD. The yield for patients with stable chest pain was lower with only 33% found to have severe CAD. Within the stable chest pain group, 330 patients (72%) were referred directly to ICA without any prior non-invasive test (such as Cardiac CT or functional tests) and of these, 30% had severe CAD.

Conclusion: We found a relatively low yield of severe CAD in patients with stable chest pain. The reasons for this are a combination of lower prevalence of CAD in current primary care populations combined with the UK NICE guidelines recommending that all patients with high PTP should have ICA using a PTP risk score that has recently been shown to overestimate risk of CAD.

Pie charts demonstrating severity of CAD

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are